
Table of Contents
Abstract ................................................................................................................................ II
Acknowledgements .............................................................................................................. III
Dedication ............................................................................................................................ IV
Table of Contents .................................................................................................................. V
List of Tables ........................................................................................................................ IX
List of Figures and Illustrations .............................................................................................. X
List of Symbols, Abbreviations and Nomenclature ................................................................ XI
Chapter One: Introduction, Hypothesis and Objective .....................................................................1
1.1 Introduction .................................................................................................................................... 2
1.1.1 Breast cancer .......................................................................................................................................... 2
1.1.1.1 Breast cancer treatment ................................................................................................................. 3
1.1.2 Tumor necrosis factor superfamily (TNFSF) ........................................................................................... 4
1.1.2.1 TNF ligands and receptors .............................................................................................................. 4
1.1.2.2 TNFSF function ................................................................................................................................ 9
1.1.3 “A proliferation-inducing ligand” (APRIL) is a member of the TNFSF of cytokines ................................ 9
1.1.3.1 APRIL gene and protein domains .................................................................................................... 9
1.1.3.2 APRIL receptors ............................................................................................................................ 12
1.1.3.3 APRIL function and signaling ........................................................................................................ 13
1.1.4 PI3K/AKT signaling in cell survival, proliferation and apoptosis. .......................................................... 14
1.1.4.1 PI3K/AKT signaling ........................................................................................................................ 14
1.1.4.2 PI3K/AKT-associated function ...................................................................................................... 16
V